Azithromycin modulates release of steroid-insensitive cytokines from peripheral blood mononuclear cells of patients with chronic obstructive pulmonary disease.
Aliaksei KadushkinAnatoli TahanovichLyudmila MovchanElina TalabayevaAlena PlastininaTatiana ShmanPublished in: Advances in respiratory medicine (2022)
Azithromycin in combination with budesonide enhances GC properties by inhibiting synthesis of pro-inflammatory cytokines in blood cells of COPD patients.